Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Laparoscopically Harvested Omental Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

NCT05979064 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT05979064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05979064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Laparoscopically Harvested Omental Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
Lead sponsor
Northwell Health
Phase
Not applicable
Overall status
Recruiting
Start date
April 4, 2023
Completion date
April 30, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, gbm, glioblastoma, glioblastoma multiforme, glioblastoma multiforme of brain, glioma, glioma, malignant, high grade glioma